Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2200
Gene Symbol: FBN1
FBN1
0.200 GeneticVariation disease BEFREE In this study, we investigated the correlations between the FBN1 genotype-phenotype and aortic events (aortic dissection and aortic aneurysm) in patients with Marfan syndrome. 31830381 2020
Entrez Id: 4015
Gene Symbol: LOX
LOX
0.330 Biomarker disease BEFREE To achieve this, we use a combination of balloon angioplasty, elastase and collagenase, and a lysyl oxidase inhibitor, called β-aminopropionitrile (BAPN), to create clinically significant infrarenal aortic aneurysms, analogous to human disease. 31814612 2019
Entrez Id: 3605
Gene Symbol: IL17A
IL17A
0.010 AlteredExpression disease BEFREE TLR4, IL-1β, IL-6 and IL-17) were detected in aortic tissues from old control people and AAA cases. 31648011 2019
Entrez Id: 406935
Gene Symbol: MIR143
MIR143
0.020 AlteredExpression disease BEFREE The results of the comparison with control group demonstrated that the increase in the expression levels of hsa‑miR‑143‑3p (P=0.017) and hsa‑miR‑22 (P=0.03) candidate miRNAs were statistically significant in the TAA group, but not in the TAD group. 31638233 2019
Entrez Id: 407004
Gene Symbol: MIR22
MIR22
0.010 Biomarker disease BEFREE The results of the comparison with control group demonstrated that the increase in the expression levels of hsa‑miR‑143‑3p (P=0.017) and hsa‑miR‑22 (P=0.03) candidate miRNAs were statistically significant in the TAA group, but not in the TAD group. 31638233 2019
Entrez Id: 1432
Gene Symbol: MAPK14
MAPK14
0.010 AlteredExpression disease BEFREE The level of expression of MAPK14 decreased in the TAD group, but increased in the TAA group compared with the control group. 31638233 2019
Entrez Id: 9314
Gene Symbol: KLF4
KLF4
0.020 Biomarker disease BEFREE Nearly half of TAA-specific miRNAs potentially regulate a key component in TGF-β signaling: TGF-β receptors, SMADs and KLF4. 31623405 2019
Entrez Id: 6590
Gene Symbol: SLPI
SLPI
0.010 AlteredExpression disease BEFREE In addition, qRT-PCR demonstrated a significant upregulation of ALK1 mRNA expression in TAA tissues. 31623405 2019
Entrez Id: 94
Gene Symbol: ACVRL1
ACVRL1
0.010 AlteredExpression disease BEFREE In addition, qRT-PCR demonstrated a significant upregulation of ALK1 mRNA expression in TAA tissues. 31623405 2019
Entrez Id: 406906
Gene Symbol: MIR122
MIR122
0.010 Biomarker disease BEFREE The panel of two plasma miRNAs, miR-122-3p, and miR-483-3p, could serve as a potential biomarker set (AUC = 0.84) for the ascending TAA. 31623405 2019
Entrez Id: 619552
Gene Symbol: MIR483
MIR483
0.010 Biomarker disease BEFREE The panel of two plasma miRNAs, miR-122-3p, and miR-483-3p, could serve as a potential biomarker set (AUC = 0.84) for the ascending TAA. 31623405 2019
Entrez Id: 406940
Gene Symbol: MIR148A
MIR148A
0.010 AlteredExpression disease BEFREE The high-throughput sequencing revealed 20 and 17 TAA-specific miRNAs in tissue and plasma samples, respectively. qRT-PCR analysis in extended cohort revealed sex-related differences in miR-10a-5p, miR-126-3p, miR-155-5p and miR-148a-3p expression, which were the most significantly dysregulated in TAA tissues of male patients. 31623405 2019
Entrez Id: 2006
Gene Symbol: ELN
ELN
0.200 Biomarker disease BEFREE AAA is characterized by the breakdown of elastin within the aortic tunica media, leading to aortic dilatation and rupture. 31595818 2019
Entrez Id: 183
Gene Symbol: AGT
AGT
0.400 Biomarker disease BEFREE Murine BM-MSCs, MSCs-CM or control medium were intravenously administrated into AngII-induced AA in apoE<sup>-/-</sup> mice. 31583844 2019
Entrez Id: 2006
Gene Symbol: ELN
ELN
0.200 AlteredExpression disease BEFREE BM-MSCs and MSCs-CM significantly attenuated matrix metalloproteinase (MMP)-2 and MMP-9 expression, aortic elastin degradation and AA growth at the site of AA. 31583844 2019
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 Biomarker disease BEFREE The current study aimed to investigate the therapeutic effects and potential mechanisms of murine bone marrow MSC (BM-MSCs)-derived conditioned medium (MSCs-CM) on angiotensin II (AngII)-induced AA in apolipoprotein E-deficient (apoE<sup>-/-</sup> ) mice. 31583844 2019
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.040 AlteredExpression disease BEFREE In addition, BM-MSCs and MSCs-CM reduced MCP-1, IL-1Ra and IL-6 expression and increased IL-10 expression in AA tissues. 31583844 2019
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.030 AlteredExpression disease BEFREE In addition, BM-MSCs and MSCs-CM reduced MCP-1, IL-1Ra and IL-6 expression and increased IL-10 expression in AA tissues. 31583844 2019
Entrez Id: 9242
Gene Symbol: MSC
MSC
0.020 Biomarker disease BEFREE These treatments with BM-MSCs and MSCs-CM also decreased Ly6c<sup>high</sup> monocytes in peripheral blood on day 7 and M1 macrophage infiltration in AA tissues on day 14, whereas they increased M2 macrophages. 31583844 2019
Entrez Id: 51312
Gene Symbol: SLC25A37
SLC25A37
0.010 Biomarker disease BEFREE These treatments with BM-MSCs and MSCs-CM also decreased Ly6c<sup>high</sup> monocytes in peripheral blood on day 7 and M1 macrophage infiltration in AA tissues on day 14, whereas they increased M2 macrophages. 31583844 2019
Entrez Id: 3557
Gene Symbol: IL1RN
IL1RN
0.010 AlteredExpression disease BEFREE In addition, BM-MSCs and MSCs-CM reduced MCP-1, IL-1Ra and IL-6 expression and increased IL-10 expression in AA tissues. 31583844 2019
Entrez Id: 847
Gene Symbol: CAT
CAT
0.020 Biomarker disease BEFREE A significant increase in the renal function markers (BUN, 240%; creatinine, 187%; and creatine kinase, 117%), oxidative stress parameters (lipid peroxidation, 192% increase; catalase, 30.5% decrease), cytokines (IL-4, 120%; TNF-<i>α</i>, 129%; and IFN-<i>γ</i>, 133%), and DNA damage was observed in the TAA-treated group. 31583036 2019
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.010 Biomarker disease BEFREE A significant increase in the renal function markers (BUN, 240%; creatinine, 187%; and creatine kinase, 117%), oxidative stress parameters (lipid peroxidation, 192% increase; catalase, 30.5% decrease), cytokines (IL-4, 120%; TNF-<i>α</i>, 129%; and IFN-<i>γ</i>, 133%), and DNA damage was observed in the TAA-treated group. 31583036 2019
Entrez Id: 3447
Gene Symbol: IFNA13
IFNA13
0.010 Biomarker disease BEFREE A significant increase in the renal function markers (BUN, 240%; creatinine, 187%; and creatine kinase, 117%), oxidative stress parameters (lipid peroxidation, 192% increase; catalase, 30.5% decrease), cytokines (IL-4, 120%; TNF-<i>α</i>, 129%; and IFN-<i>γ</i>, 133%), and DNA damage was observed in the TAA-treated group. 31583036 2019
Entrez Id: 3565
Gene Symbol: IL4
IL4
0.010 Biomarker disease BEFREE A significant increase in the renal function markers (BUN, 240%; creatinine, 187%; and creatine kinase, 117%), oxidative stress parameters (lipid peroxidation, 192% increase; catalase, 30.5% decrease), cytokines (IL-4, 120%; TNF-<i>α</i>, 129%; and IFN-<i>γ</i>, 133%), and DNA damage was observed in the TAA-treated group. 31583036 2019